BRAF R558Q

CI-VAR-00003866Explore in graph →CIViC 2803

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Unmapped disease1unmapped disease
BRAF R558Q	(functional)	Functional	D	Supports Gain Of Function	4	submitted	EID7577 BRAF R558Q led to modest activation of ERK signaling. This activation was abrogated by the R558Q mutation, indicating that this mutation requires dimerization to signal. Also, the absence of RAS expre… (full text at CIViC) PMID 31515458 · Yaeger et al., 2019 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.